HOME HELP SUBSCRIBE ARCHIVE SEARCH TABLE OF CONTENTS FEEDBACK EDITORIAL BOARD ABOUT DOC NEWS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Services Email this article to a friend Similar articles in this journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                What's this?

Diabetes Not a Risk for Percutaneous Coronary Intervention

Mohammed Andron, MD, and colleagues at the Cardiothoracic Centre in Liverpool, England, studied in-hospital major adverse cardiac and cerebrovascular events (MACCEs) and one-year clinical outcomes following successful coronary stent placement. The study included 4,891 consecutive patients who were treated during 2000–2004, 674 of whom (13.8%) had diabetes.

The group found that the risk of inhospital MACCEs and outcomes at 1 year were similar for patients with and without diabetes. Neither were there differences in the risk of death or target lesion revascularization (TLR) based on diabetes status.

However, when TLR was sorted based on the type of stent used, people with diabetes tended to have a higher rate of TLR when given a bare metal stent and a lower rate of TLR when given a drug-eluting stent, compared to patients without diabetes.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

Services Email this article to a friend Similar articles in this journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                What's this?